“…The great majority of malaria cases in the world occur in tropical Africa where the disease is esti mated to cause 0.5-1 million deaths per year [2], In Mozambique malaria constitutes one of the principal health problems. In 1975/1976 malaria prevalence was over 40%, but the situation has worsened due to the appearance of chloroquine resistance [3], One serious consequence of this is the deterioration of maternal and child health [1], Pregnant women are more affected by malaria than non-pregnant women both in types with few symptoms [4] and in types with more acute symptoms [5], The situation might be worsened by inadequate therapy and by a diminishing protective immunity [6,7], In many cases malaria is complicated by a serious maternal anaemia, above all in the second trimester [5,8], Malarial complications of the fetus comprise fetal loss and prema turity [4], retarded intra-uterine growth [9,10], decreased passage of IgG [7,9] and congenital malaria [ 1,[11][12][13][14][15], Placental malaria is described in the literature as an entity associated with an increase in placental surface parasitaemia [13] with associated tissular changes in the blood cell membrane and in the trophoblastic cells [9], There seems to be auto-agglutination and fibrine aggrega tion in the intervillous space with deposition of malarial pigment and mononuclear cell infiltration [16],…”